# FinVector Oy – FDA 483, Mar 4, 2026

Source: https://www.keypedia.com/records/483/finvector-oy/fd6ac7fb-6403-41ac-8e7d-fef0a90f421b

> FDA 483 for FinVector Oy on March 04, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: FinVector Oy
- Inspection Date: 2026-03-04
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Operations
- Summary: FinVector Oy, a drug substance manufacturer in Kuopio, Finland, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate data integrity for batch production records, ineffective management of deviations and corrective actions for recurring issues like HEPA filter leakages and pest infestations, and failure to follow written production procedures. Additionally, critical manufacturing materials were not routinely monitored, and cleaning procedures for the raw materials warehouse were not established.

## Related Documents

- [483 - 2024-05-28](https://www.keypedia.com/records/483/finvector-oy/b1f698cf-2a2f-48d2-99c8-cdacc475988c) — date: May 28, 2024
- [483](https://www.keypedia.com/records/483/finvector-oy/aedbde8d-a25b-44a7-b6b2-7536a0dad18d)
- [483](https://www.keypedia.com/records/483/finvector-oy/6a821dbe-4cfd-47f2-9668-88826378264b)

## Related Officers

- [Nicole M. Li](https://www.keypedia.com/people/nicole-m-li/cfffdaa1-4ed3-43a3-81fc-03ddc459c564)

Company: https://www.keypedia.com/companies/finvector-oy/880a8467-a5a4-431b-b597-7dd6e59b185b

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-operations/27658190-735a-443e-9087-3534cfe74fd4